Quest Diagnostics

Update in progress

DGX (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryDiagnostics & Research

Quest Diagnostics Incorporated delivers diagnostic testing and related information services in the United States. It provides routine, advanced and specialized clinical testing, anatomic pathology, and other diagnostic information services under the Quest Diagnostics brand and through AmeriPath, Dermpath Diagnostics, ExamOne and Quanum. Serving physicians, hospitals, patients, payers, employers and health plans, it operates laboratories, service centers, phlebotomy networks and digital health solutions. Founded 1967, Secaucus, NJ.

Company score

Sentiment: 0.98; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.14; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.97; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.32; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.40; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.69; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive